Carregant...
IN THE PRESENCE OF STRONG P2Y(12) RECEPTOR BLOCKADE, ASPIRIN PROVIDES LITTLE ADDITIONAL INHIBITION OF PLATELET AGGREGATION
BACKGROUND: Aspirin and antagonists of platelet ADP P2Y(12) receptors are often co-prescribed for protection against thrombotic events. However, blockade of platelet P2Y(12) receptors can inhibit thromboxane A(2) (TXA(2)) dependent pathways of platelet activation independently of aspirin. OBJECTIVES...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3064407/ https://ncbi.nlm.nih.gov/pubmed/21143373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1538-7836.2010.04160.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|